chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose decreased, Death, Mental status changes, Sepsis, Shock
Clinical narrative: Narrative:  Pt is a 87y.o. male who died on 02/12/2021 w/ h/o CKD4, Lung cancer, HTN, BPH, HLD. Pt received Moderna Covid-19 Vaccination 1/2 on 01/15/2021. Pt presented to ED on 02/11/2021 with low BS and AMS. Palliative Care consult 02/12/2021 with pt transitioned to comfort care. Pt died while inpatient on 02/12/2021 with physician reporting "Death was caused by: Severe sepsis with shock from urinary tract infection". Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Narrative:  Pt is a 87y.o. male who died on 02/12/2021 w/ h/o CKD4, Lung cancer, HTN, BPH, HLD. Pt received Moderna Covid-19 Vaccination 1/2 on 01/15/2021. Pt presented to ED on 02/11/2021 with low BS and AMS. Palliative Care consult 02/12/2021 with pt transitioned to comfort care. Pt died while inpatient on 02/12/2021 with physician reporting "Death was caused by: Severe sepsis with shock from urinary tract infection". Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Fluid retention, Tachypnoea, Wheezing
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for heart block, advanced age (93), CHF, arrhythmia, chronic obstructive lung disease, hypertensive heart disease, AF on hospice care. He presented to ED 5/11 for shortness of breath. Returned on 5/13 for tachypneic with labored breathing with wheezing symptoms and fluid retention. Discharged 5/20 and deceased 5/23.
Age: 101.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Pt is a 99y.o. male who died on 02/19/2021 w/ h/o CA Prostate, SCC, pacemakers, HTN, AFib, OA, PAD. PT received Pfizer Covid-19 Vaccination 1/2 on 1/14/2021. Facility was notified of pt death on 03/15/2021 by administration. Unlikely that Pfizer Covid-19 Vaccine caused/contributed to pt death.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Agitation, Anticoagulant therapy, Anticoagulation drug level below therapeutic, Catheterisation cardiac
Clinical narrative: Narrative:  63y.o. MALE with a h/o CAD s/p CABG 2014, COPD not on home O2, Mechanical Mitral valve replacement (hx of noncompliance with AC),Hfpef (EF 50% 2016),treated Hep C s/p harvoni tx, HTN presented to ER on 5/20/21 for shortness of air for the past 3 weeks. Patient was recently discharged from medical center 4/1/21 for copd exacerbation, pneumonia sent home on oral antibiotics. Pt with -Subtheruaputic INR POA: -Mechanical mitral valve, non adherent with AC POA: Started on Heparin gtt here, will resume warfarin after eval by pulm and pharm to follow. Heart cath performed on 5/24/21. Pt agitated and left AMA on 5/24/21. Notes in CPRS not able to reach pt by phone on 5/25/21 for post AMA followup. Per CPRS note pt deceased on 6/3/21 reported to medical center from community hospital where pt died. Pt had presented to this community ER on 6/3/21 with ST ELEVATED MYOCARDIAL INFARCTION diagnosis. Likely death not related to covid vaccinations given on 5/7/21 & 4/7/21.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Treatment noncompliance
Clinical narrative: Narrative:  63y.o. MALE with a h/o CAD s/p CABG 2014, COPD not on home O2, Mechanical Mitral valve replacement (hx of noncompliance with AC),Hfpef (EF 50% 2016),treated Hep C s/p harvoni tx, HTN presented to ER on 5/20/21 for shortness of air for the past 3 weeks. Patient was recently discharged from medical center 4/1/21 for copd exacerbation, pneumonia sent home on oral antibiotics. Pt with -Subtheruaputic INR POA: -Mechanical mitral valve, non adherent with AC POA: Started on Heparin gtt here, will resume warfarin after eval by pulm and pharm to follow. Heart cath performed on 5/24/21. Pt agitated and left AMA on 5/24/21. Notes in CPRS not able to reach pt by phone on 5/25/21 for post AMA followup. Per CPRS note pt deceased on 6/3/21 reported to medical center from community hospital where pt died. Pt had presented to this community ER on 6/3/21 with ST ELEVATED MYOCARDIAL INFARCTION diagnosis. Likely death not related to covid vaccinations given on 5/7/21 & 4/7/21.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: Narrative: pt reported numbness of her lips after  receiving her second dose of moderna covid vax.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Narrative:  hospitalized with symptomatic covid after being fully vaccinated
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness
Clinical narrative: Narrative:  Patient reports that his "equilibrium was off" after getting his first COVID vaccine. He also felt dizziness after getting his second COVID vaccine.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Narrative: Patient called to report itching of head, neck, arm on 5/18/2021 after  2nd dose of vaccine 5/11/2021. Onset not stated. Difficulty calling patient back--  on 5/20/21 the patient reported the itching was improved. Diphenhydramine or  cetirizine OTC was offered to the patient.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Hyperhidrosis, Pain in extremity, Pyrexia
Clinical narrative: Fever, Diarrhea, ABDOMINAL PAIN, ARM PAIN, DIAPHORESIS Narrative:
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Death, Hemiparesis
Clinical narrative: Narrative:  Pt was a 85y.o. male who died on 05/06/2021 has h/o CKD3, HLD, HTN, and pancreatic cancer. He received Modern Covid-19 vaccination on 03/13/2021. Pt admitted to Hospital with acute right-sided stroke and left hemiparesis and eventually transition to comfort measures admitted to the hospital for inpatient hospice care (5/4/2021).
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: AST/ALT ratio, Anaemia, Asthenia, Blood calcium decreased, Blood chloride normal
Clinical narrative: Narrative:  Patient presented to hospital with generalized weakness, failure to thrive, severe anemia, limited cardiac reserves and progressive declined in setting of progressive right heart failure (significant pleural effusion requiring drainage every 2-4 weeks). Patient also noted to have pericardial effusion. Unknown hemoglobin pathology as patient's fingers appear purple and hemoglobin untestable due to the presence of cold agglutinins. Daughter reports patient progressively weak over last three months onset after 1st COVID vaccine. Patient previously used cane for assistance now using walker last three months. Daughters noticed rapid decline since week prior to admission after a fall. Patient previously had symptomatic improvement with pleural fluid drainage but patient did not improve after last drainage (5/27/21). Patient very weak and fragile with increased work of breathing and very low exertion tolerance. Hospice consult. Patient converted to hospice/comfort care. Discharged from hospital for end of life/hospice care. Patient's family expressed concern about timeframe corresponding to post-vaccinations series. Provider wonders if cold agglutinin disease could have been triggered by vaccine. Patient died 6/26/21.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatine phosphokinase decreased, Blood creatinine normal, Blood magnesium increased, Blood phosphorus normal, Blood potassium normal
Clinical narrative: Narrative:  Patient presented to hospital with generalized weakness, failure to thrive, severe anemia, limited cardiac reserves and progressive declined in setting of progressive right heart failure (significant pleural effusion requiring drainage every 2-4 weeks). Patient also noted to have pericardial effusion. Unknown hemoglobin pathology as patient's fingers appear purple and hemoglobin untestable due to the presence of cold agglutinins. Daughter reports patient progressively weak over last three months onset after 1st COVID vaccine. Patient previously used cane for assistance now using walker last three months. Daughters noticed rapid decline since week prior to admission after a fall. Patient previously had symptomatic improvement with pleural fluid drainage but patient did not improve after last drainage (5/27/21). Patient very weak and fragile with increased work of breathing and very low exertion tolerance. Hospice consult. Patient converted to hospice/comfort care. Discharged from hospital for end of life/hospice care. Patient's family expressed concern about timeframe corresponding to post-vaccinations series. Provider wonders if cold agglutinin disease could have been triggered by vaccine. Patient died 6/26/21.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium normal, Blood urea increased, Blood uric acid normal, Carbon dioxide normal, Cardiac dysfunction
Clinical narrative: Narrative:  Patient presented to hospital with generalized weakness, failure to thrive, severe anemia, limited cardiac reserves and progressive declined in setting of progressive right heart failure (significant pleural effusion requiring drainage every 2-4 weeks). Patient also noted to have pericardial effusion. Unknown hemoglobin pathology as patient's fingers appear purple and hemoglobin untestable due to the presence of cold agglutinins. Daughter reports patient progressively weak over last three months onset after 1st COVID vaccine. Patient previously used cane for assistance now using walker last three months. Daughters noticed rapid decline since week prior to admission after a fall. Patient previously had symptomatic improvement with pleural fluid drainage but patient did not improve after last drainage (5/27/21). Patient very weak and fragile with increased work of breathing and very low exertion tolerance. Hospice consult. Patient converted to hospice/comfort care. Discharged from hospital for end of life/hospice care. Patient's family expressed concern about timeframe corresponding to post-vaccinations series. Provider wonders if cold agglutinin disease could have been triggered by vaccine. Patient died 6/26/21.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Cold agglutinins positive, Cold type haemolytic anaemia, Death, Dyspnoea, Exercise tolerance decreased
Clinical narrative: Narrative:  Patient presented to hospital with generalized weakness, failure to thrive, severe anemia, limited cardiac reserves and progressive declined in setting of progressive right heart failure (significant pleural effusion requiring drainage every 2-4 weeks). Patient also noted to have pericardial effusion. Unknown hemoglobin pathology as patient's fingers appear purple and hemoglobin untestable due to the presence of cold agglutinins. Daughter reports patient progressively weak over last three months onset after 1st COVID vaccine. Patient previously used cane for assistance now using walker last three months. Daughters noticed rapid decline since week prior to admission after a fall. Patient previously had symptomatic improvement with pleural fluid drainage but patient did not improve after last drainage (5/27/21). Patient very weak and fragile with increased work of breathing and very low exertion tolerance. Hospice consult. Patient converted to hospice/comfort care. Discharged from hospital for end of life/hospice care. Patient's family expressed concern about timeframe corresponding to post-vaccinations series. Provider wonders if cold agglutinin disease could have been triggered by vaccine. Patient died 6/26/21.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Failure to thrive, Fall, General physical health deterioration, Glomerular filtration rate decreased, Haematocrit decreased
Clinical narrative: Narrative:  Patient presented to hospital with generalized weakness, failure to thrive, severe anemia, limited cardiac reserves and progressive declined in setting of progressive right heart failure (significant pleural effusion requiring drainage every 2-4 weeks). Patient also noted to have pericardial effusion. Unknown hemoglobin pathology as patient's fingers appear purple and hemoglobin untestable due to the presence of cold agglutinins. Daughter reports patient progressively weak over last three months onset after 1st COVID vaccine. Patient previously used cane for assistance now using walker last three months. Daughters noticed rapid decline since week prior to admission after a fall. Patient previously had symptomatic improvement with pleural fluid drainage but patient did not improve after last drainage (5/27/21). Patient very weak and fragile with increased work of breathing and very low exertion tolerance. Hospice consult. Patient converted to hospice/comfort care. Discharged from hospital for end of life/hospice care. Patient's family expressed concern about timeframe corresponding to post-vaccinations series. Provider wonders if cold agglutinin disease could have been triggered by vaccine. Patient died 6/26/21.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Pericardial effusion, Platelet count normal, Pleural effusion, Red blood cell count decreased
Clinical narrative: Narrative:  Patient presented to hospital with generalized weakness, failure to thrive, severe anemia, limited cardiac reserves and progressive declined in setting of progressive right heart failure (significant pleural effusion requiring drainage every 2-4 weeks). Patient also noted to have pericardial effusion. Unknown hemoglobin pathology as patient's fingers appear purple and hemoglobin untestable due to the presence of cold agglutinins. Daughter reports patient progressively weak over last three months onset after 1st COVID vaccine. Patient previously used cane for assistance now using walker last three months. Daughters noticed rapid decline since week prior to admission after a fall. Patient previously had symptomatic improvement with pleural fluid drainage but patient did not improve after last drainage (5/27/21). Patient very weak and fragile with increased work of breathing and very low exertion tolerance. Hospice consult. Patient converted to hospice/comfort care. Discharged from hospital for end of life/hospice care. Patient's family expressed concern about timeframe corresponding to post-vaccinations series. Provider wonders if cold agglutinin disease could have been triggered by vaccine. Patient died 6/26/21.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Right ventricular failure, SARS-CoV-2 test negative, Skin discolouration, Thoracic cavity drainage
Clinical narrative: Narrative:  Patient presented to hospital with generalized weakness, failure to thrive, severe anemia, limited cardiac reserves and progressive declined in setting of progressive right heart failure (significant pleural effusion requiring drainage every 2-4 weeks). Patient also noted to have pericardial effusion. Unknown hemoglobin pathology as patient's fingers appear purple and hemoglobin untestable due to the presence of cold agglutinins. Daughter reports patient progressively weak over last three months onset after 1st COVID vaccine. Patient previously used cane for assistance now using walker last three months. Daughters noticed rapid decline since week prior to admission after a fall. Patient previously had symptomatic improvement with pleural fluid drainage but patient did not improve after last drainage (5/27/21). Patient very weak and fragile with increased work of breathing and very low exertion tolerance. Hospice consult. Patient converted to hospice/comfort care. Discharged from hospital for end of life/hospice care. Patient's family expressed concern about timeframe corresponding to post-vaccinations series. Provider wonders if cold agglutinin disease could have been triggered by vaccine. Patient died 6/26/21.
Age: 98.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin T normal, Walking aid user, White blood cell count normal
Clinical narrative: Narrative:  Patient presented to hospital with generalized weakness, failure to thrive, severe anemia, limited cardiac reserves and progressive declined in setting of progressive right heart failure (significant pleural effusion requiring drainage every 2-4 weeks). Patient also noted to have pericardial effusion. Unknown hemoglobin pathology as patient's fingers appear purple and hemoglobin untestable due to the presence of cold agglutinins. Daughter reports patient progressively weak over last three months onset after 1st COVID vaccine. Patient previously used cane for assistance now using walker last three months. Daughters noticed rapid decline since week prior to admission after a fall. Patient previously had symptomatic improvement with pleural fluid drainage but patient did not improve after last drainage (5/27/21). Patient very weak and fragile with increased work of breathing and very low exertion tolerance. Hospice consult. Patient converted to hospice/comfort care. Discharged from hospital for end of life/hospice care. Patient's family expressed concern about timeframe corresponding to post-vaccinations series. Provider wonders if cold agglutinin disease could have been triggered by vaccine. Patient died 6/26/21.
Age: 57.0
Sex: F
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 83 y.o. patient who received dose #1 of Moderna COVID vaccine (Lot #07B21A, exp 9/8/21) on 3/29/21 and dose #2 of Moderna COVID vaccine (Lot # 037B21A, exp 10/1/21) on 4/26/21. PMH including head and neck cancer, ESRD, DM, HTN, HLD, afib, OSA, COPD, asthma, OA, low back pain, and obesity. He was admitted to hospital on 1/20/21 for shortness of breath and acute hypoxia. He was found to be Covid positive. His acute hypoxic respiratory failure was management with oxygen and home inhalers. On admission, he had acute kidney injury which progressed to ESRD, etiology thought to be from Covid infection vs chemotherapy. He was started on dialysis on acute floor. Patient had a chronic thrombotic occlusion on left side vessels so a left femoral perm cath placed on 3/20/21. Patient was initially transferred to nursing home on 3/29/21 for rehab due to multiple comorbidities and debility from chemoradiation. On 3/31/21, he returned ASIH to step down unit due to atrial flutter with RVR during dialysis with rate in 140-160s with low pressure systolic in 70-80s. During ASIH, it was determined the atrial flutter with RVR during dialysis sessions was related to volume depletion, responsive to fluids and beta blockade. He was seen by palliative care during acute hospital stay and ASIH. Patient returned to nursing home on 4/13/21 as a long stay continuing care. Transitioned to hospice/palliative 4/23 as was not tolerating dialysis. Patient passed away in the nursing home on 5/2/21 @ 1345. Reaction classified as severe as death occurred following vaccination.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Narrative:  No adverse reactions or outcomes. Pt had Moderna vaccine February 10,2021. He stated that he did not remember receiving that vaccine. Janssen vaccine was administered Jun 15, 2021. Pharmacy notified. He stated that he did not need to have any additional doses since he had a valid dose with the Janssen.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: Narrative:  Admitted to Medical Center on 4/24/21 with R leg DVT. Received Pfizer shot on 2/24/21
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pain, Pain in extremity
Clinical narrative: ARM PAIN, BODY ACHES, MIGRAINE Narrative:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None stated
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Impaired work ability
Clinical narrative: Employee Reported symptoms debilitating requiring them to use  leave. Did not clarify Symptoms for calling out of work for 2  days. Narrative:
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt is a 89y.o male who died on 03/02/2021 w/ h/o dementia, prostate cancer, BCC,BPH, HLD, gout. Pt received Moderna Covid-19 Vaccination 1/2 on 01/08/2021. Pt died at home on 03/02/2021. Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  93 yo m with hx of cad s/p remote cabg, htn, hld, rheumatoid , bph/urinary retention s/p remote TURP died on 2/10/2021.Pt had received one dose of covid vaccine on 1/13/2021. Mostly likely death unrelated to vaccine. Pt died when outpatient with no notes available in database regarding pt's death.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Endotracheal intubation, Hypoxia, Leukocytosis
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for malignant neoplasm of lung, pvd, carotid artery stenosis, hyperlipidemia, coronary atherosclerosis, HTN. Pt presented to ED on 4/19/21 with CC of SOB x 3 days. Received antibiotics for multifocal pneumonia, tested negative for covid. He was found to have worsening leukocytosis, renal function and hypoxia on 4/24. Was intubated with vasopressors and septic but did not improve. Was extubated. Deceased 5/1/2021.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Renal impairment, SARS-CoV-2 test negative, Sepsis
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for malignant neoplasm of lung, pvd, carotid artery stenosis, hyperlipidemia, coronary atherosclerosis, HTN. Pt presented to ED on 4/19/21 with CC of SOB x 3 days. Received antibiotics for multifocal pneumonia, tested negative for covid. He was found to have worsening leukocytosis, renal function and hypoxia on 4/24. Was intubated with vasopressors and septic but did not improve. Was extubated. Deceased 5/1/2021.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Headache, Lymphadenopathy
Clinical narrative: Headache left arm/hand swelling, fatigue, weakness, swollen glands, chills Narrative:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Headache left arm/hand swelling, fatigue, weakness, swollen glands, chills Narrative:
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received one dose of covid vaccine. Patient had active lung cancer. Patient passed away in home, no further details related to death. Reporting per Network instructions.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fall, Lethargy, Pyrexia
Clinical narrative: Narrative:  Pt received second COVID-19 vaccine dose 3/27/21. Reported feeling weak and lethargic after receiving vaccine and fell out of shower chair 3/28; admitted for evaluation. Developed isolated fever of 101.4 F on 3/30. Notes suggest sx possibly post-vaccine related. Sx resolved and pt discharged 3/31.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Patient reports slight runny nose after first  COVID vaccine.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt is a 92y.o. male who died on 05/04/2021 with h/o DM. Pt received Pfizer Covid-19 vaccination on 01/14/2021. Unlikely Pfrizer Covid-19 caused/contributed to pt death.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Narrative:  Patient reports skin rash on the chest, neck, arms, and legs after administration of the second COVID vaccine.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Migraine, Nausea
Clinical narrative: LIGHTHEADED, MIGRAINE, NAUSEA Narrative:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Narrative:  Pt. received pfizer second vaccine. Reported feeling dizziness. Water given and symptoms improved. Vital signs stable.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Narrative: Pt at DOM received 2nd dose of Covid-19 Moderna vaccine on 2/2/21. On 2/3/21. pt. reported to RN station with complaints of mental fogginess; denied lightheadedness, dizziness, SOB, or difficult breathing, Vital signs stable. Encouraged increased fluid intake and rest as needed.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:  Per LPN, HAD 1ST DOSE 1/16/21 AT LOCAL PHARMACY CARDIOLOGIST ROCOMMENDED THAT PT NOT HAVE 2ND  DOSE DUE TO SEVERE SIDE EFFECTS The patient was instructed to bring a copy of their COVID-19 vaccine information to their next appointment so that this can be accurately recorded in the medical record.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Death, Psoriasis
Clinical narrative: Narrative: Patient received Moderna covid #1 on 4/1/21. On 4/6/21, he was contacted by agency and reported that all was well with him. Agency made other attempts to contact him on 5/7/21 and 5/13/21 and were unsuccessful. On 5/14/21, when they went to his apartment, they were notified that he was found deceased inside his apartment on 5/10/21. Only scanned records were from a orthopedic visit on 4/9/21 for bilateral knee pain and a dermatology visit on 4/20/21 for psoriasis and history of basal cell carcinoma. No notes to indicate what happened from time of vaccine to date of death (39 days). No autopsy report available.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Completed suicide, Depression, Schizoaffective disorder
Clinical narrative: Narrative:  Patient received Moderna covid #1 on 3/23/21 and #2 on 4/20/21. On 5/18/21, he received an injection of haloperidol decanoate 100mg for schizoaffective disorder with depression. No other scanned records from that time to his date of death recorded as 5/4/21. He does have a note entered that states cause of death as suicide by firearm. Time from second vaccine to date of death was 34 days.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative: Timing error, 2nd dose given too soon 15 days after first dose.  Veteran stayed and received the required 15 min observation, no  complaints voiced or symptoms of distress noted.
Age: 100.0
Sex: M
Vaccine: COVID19
Symptoms: Cellulitis, Death, Dementia, Fall
Clinical narrative: Narrative:  99yo male with symptoms of dementia, chronic cellulitis and frequent falls requiring 24/7 supervision and care by family. Family called to notify medical facility pt had passed away at home on 5/13/2021. Pt had received both covid vaccines on 2/6/21 & 4/19/21. Pt was in palliative care medical care. Appears death is not related to vaccinations given. .
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac aneurysm, Cardiac arrest, Death, Syncope
Clinical narrative: Narrative:  Pt with medical history of: 1. Recent STEMI involving left circumflex coronary artery - s/p PCI w/ rotational arherectomy and durg eluting stent placement of the left main to LAD w/ Impella on 5/4/21. 2. CAD native coronary artery - no angina, on clopidogrel 75mg daily, NTG-SL 0.4mg; ASA 81mg daily 3. Ischemia cardiomyopathy - EF 28%; on furosemide 20mg daly; managed by Dr 4. Hypertension - well controlled w/ metoprolos succinate XL 25mg daily 5. Hyperlipidemia - cont atorvastatin 40mg hs Also had received one dose of covid moderna vaccine on 5/14/21. Pt self present to outside community hospital ER diagnosed with syncope & ventricular wall aneurysm on 5/25/2021. Pt died of "cardiac arrest" on 5/25/2021 at community hospital. Death appears unrelated to covid vaccination.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Anorectal operation, Death
Clinical narrative: Narrative:  61 yo male h/o HIV+, h/o severe polysubstance use disorders in remission, colostomy creation February 2020 and take down October 2020. Patient had support from and much success with MH and substance abuse treatment program until February 2021.Patient had 2nd dose of Pfizer COVID-19 Vaccine on 29 March 2021. He had an Outpatient colorectal surgery appt in clinic on 31 March 2021. Chart says that he passed on 31 March 2021, the same day as that last appt. No pertinent information about the circumstances/cause of the death, but medical examiner was involved.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain, Pyrexia
Clinical narrative: Headache, Myalgia & Fever Narrative: Patient reports experiencing symptoms of headaches, body aches, and  fever (102 F) beginning the day after receiving the second dose of the vaccine.  Denies any previous reactions to any prior vaccines. reports used Tylenol (no dose/frequency provided)  for symptom relief. Did not report to PCP or urgent care for symptoms.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: Narrative: Headache, Fever, Sore Throat. All symptoms developed 8 days after Vaccination
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chest X-ray abnormal, Death, Decreased appetite, Dyspnoea
Clinical narrative: Narrative:  Patient received Moderna Covid vaccine #1 on 3/5/21 and #2 on 4/2/21. On 3/9/21, he did have reports of poor appetite and weakness to his PCP and on 3/17/21, home health nurse reported an injury to his shin and bilateral pitting edema. On 4/8/21, he presented to our urgent care clinic with reports of shortness of breath and had a chest xray done that showed a right pleural effusion. PMH is significant for CHF and a liver mass seen on MRI 11/2020. He was then transferred to a facility and admitted that same day. On 4/16/21, a hospice consult was placed and he discharged home with home hospice services. On 5/5/21, it was reported that he passed away. Time from second vaccine to date of death was 33 days. No autopsy reports available.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Limb injury, Oedema, Pleural effusion
Clinical narrative: Narrative:  Patient received Moderna Covid vaccine #1 on 3/5/21 and #2 on 4/2/21. On 3/9/21, he did have reports of poor appetite and weakness to his PCP and on 3/17/21, home health nurse reported an injury to his shin and bilateral pitting edema. On 4/8/21, he presented to our urgent care clinic with reports of shortness of breath and had a chest xray done that showed a right pleural effusion. PMH is significant for CHF and a liver mass seen on MRI 11/2020. He was then transferred to a facility and admitted that same day. On 4/16/21, a hospice consult was placed and he discharged home with home hospice services. On 5/5/21, it was reported that he passed away. Time from second vaccine to date of death was 33 days. No autopsy reports available.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Lethargy, Surgery, Vomiting
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for hx of cerebrovascular accident, t2dm, htn, hyperlipidemia. Per note 4/7, patient was taken to ER with a cc of vomiting and lethargy. Next note was 4/27 which daughter reported that patient was still in the hospital (had 2 surgeries) and inquiring about home health. Patient discharged on 4/29 and deceased 9 hours later. Lack of information available regarding hospital visit and death.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt is an 88 yo male with PMH of CAD, CVA, aortic stenosis, HTN, HLD, and carotid artery stenosis. Death was reported to medical facility by coroner's office. Nothing reported in chart to suggest death was caused by vaccination.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: Narrative: Patient reported injection site rash that resolved day after vaccination
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia
Clinical narrative: Narrative:  Patient experienced chills, fatigue, muscle aches, and headache after receiving the first COVID-19 vaccination dose.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site pruritus, Injection site swelling
Clinical narrative: Narrative: Patient experienced swelling and pruritis of the injection site after receiving the second COVID-19 vaccination dose.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state
Clinical narrative: Narrative: intermittent confusion noted in hospice notes.
Age: 56.0
Sex: M
Vaccine: FLUX
Symptoms: Guillain-Barre syndrome
Clinical narrative: Narrative:  Pt received influenza vaccine outside the facility per PCP ADR note, GBS occurred 2 days post-vaccine. Pt newly established care at facility - unclear exact date/time of details of influenza vaccine.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Narrative: Patient experienced muscle pain in the shoulder after receiving the first dose of the COVID-19 series.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash maculo-papular, Rash pruritic
Clinical narrative: Narrative:  On 2/19/21 patient had Moderna Covid-19 vaccine #1, then 2 days later developed a rash on the trunk, which spread to extremities. He also had seafood recently and so cause of rash unclear at the time. He subsequently had vaccine dose #2 in 3/2021 and developed pruritic maculopapular rash again (no recent seafood or other changes) that manifested over the same time course, symptoms appearance and pattern of spread - trunk -> extremeties .
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation abnormal
Clinical narrative: Narrative: Patient with a history of COPD (baseline oxygen saturation 96-97%) reported experiencing oxygen saturation fluctuation from 91-92% down to 88% after receiving second COVID-19 dose (no documentation available), Symptoms improved with nebulizer use every 4 hours. Patient was advisd to seek  emergency care for extreme shortness of breath of other severe symptoms. Patient recovered without the need for further evaluation
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. 64 y/o male with HTN, HLD, DMII, ETOH abuse, Tobacco use, chronic pancreatitis/b exocrine insufficiency on PERT, multiple pseudocysts and splenic vein thrombosis on anticoagulation. On March 06th patient was also admitted to ER for upper abdominal pain after eating. Also had an history of Pancreatitis.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood creatinine increased, Platelet count normal
Clinical narrative: Narrative: Anticoagulation started. Heme/Onc consulted, results pending.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Dyspnoea, Palpitations, Throat tightness
Clinical narrative: Narrative:  Patient reports that she waited the 15 minutes, but 10 minutes after that she began to have sx of heart palpitations, racing, dry throat, she felt like her throat was closing up and felt her breathing was restricted. This last about 5 hours total and gradually resolved. She states that she felt continuous drinking water helped her feel like it was keeping her throat open. She states that she felt restricted but was still able to breathe.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Fatigue, Feeling hot, Loss of consciousness, Nausea
Clinical narrative: Narrative:  Patient received Pfizer vaccine 1st dose. Approximately 5 minutes after vaccine administration patient reported being "thirsty" was able to ambulate by self and then patient then fell forward after sitting down in a chair in the vaccine monitor room. Patient reports feeling nauseous, tired, hot, and reports thinking he blacked out. Patient had vital signs taken 140/69, 89 HR, 97% RA, 20 R, and denies pain. A rapid response was called and patient was escorted to ER by RN.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Thirst
Clinical narrative: Narrative:  Patient received Pfizer vaccine 1st dose. Approximately 5 minutes after vaccine administration patient reported being "thirsty" was able to ambulate by self and then patient then fell forward after sitting down in a chair in the vaccine monitor room. Patient reports feeling nauseous, tired, hot, and reports thinking he blacked out. Patient had vital signs taken 140/69, 89 HR, 97% RA, 20 R, and denies pain. A rapid response was called and patient was escorted to ER by RN.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Injection site pain, Injection site swelling, Nausea
Clinical narrative: Narrative: Patient experienced injection site soreness and swelling as well as dizziness and nausea after receiving the first dose of the COVID-19 vaccine.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Narrative: Patient reports that symptoms of pain following vaccine presently continue at time of this note ~4 weeks since vaccination. Documenting reaction as severe due to cause of longstanding health issue,
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Pain, Pain in extremity
Clinical narrative: Narrative: Patient experienced joint pain and swelling approximately 1 hour after receiving the second COVID-19 vaccine. Patient reported having this hand pain before, but at the time of the reaction it had extended to the wrist and the pain severity had increased
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Flushing, Headache, Hyperhidrosis, Pharyngeal swelling
Clinical narrative: Narrative: Patient reported feeling flushed, experienced diaphoresis, and had a  little bit of swelling on the right side of the throat. It was also reported that the patient experienced joint pain, headache, and a slight fever, All symptoms resolved within a few days.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Narrative: Patient reported feeling flushed, experienced diaphoresis, and had a  little bit of swelling on the right side of the throat. It was also reported that the patient experienced joint pain, headache, and a slight fever, All symptoms resolved within a few days.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Muscle twitching, Pain, Pyrexia
Clinical narrative: Narrative:  Patient experienced body aches, chills, twitching, and fever after receiving the second dose of the COVID-19 vaccine.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Nerve compression, Pain in extremity
Clinical narrative: Narrative:  Patient experienced pain in the leg after receiving a COVID-19 vaccination in her left deltoid. Patient believed that there was a pinched nerve in the leg.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Narrative:  Patient developed a headache that lasted for several weeks after receiving the first COVID-19 dose that he reported was dull, moved around, and felt like it was in the spine/neck and radiating to behind the left ear. Patient denied any known injury and was able to turn his neck from side to side with some pain when turning to the left and no pain when tucking chin to chest. Symptoms resolved and did not occur with the second COVID-19 vaccine.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative:  Timing error, 2nd dose given too soon 14 days after 1st dose.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Narrative: patient experienced dizziness and nausea 7-8 hours after receiving the COVID vaccine.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Dyspnoea, Hyperventilation
Clinical narrative: Narrative: Per PCP note on 03/03/2021, "I spoke w/the pt's wife (pt w/ dementia) who received his covid vaccine in early february. Pt was fine but at night the pt started to take deeper breaths. Wife noted he was somewhat agitated and felt he was having some sob. There was no cough, no URI sx's, no wheezing, no rash or hives, no obvious tongue or face swelling. Pt improved after a neb tx. Pt was not sick before his vaccine and his sx's resolved after his nebulizer tx. In am he was given a second tx and has been fine since. Pt's wife is concerned and wants to now if he should get his second vaccine. I recommended for her to not give him his second vaccine. If the Johnson and johnson vaccine becomes available they can aske for that one. Wife agreed to hold the second vaccine."
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Narrative: A 41yo, male reported with historical ADR of Pfizer Covid -19 vaccine induced rash. It was reported as observed on February 24, 2021 and classified as moderate, by the patient's Psychiatrist who reported it on March 19, 2021 Per February 19, 2021 Psychiatry note, his PMH included HTN, HLD, Anxiety and PTSD No other detailed information in the Facility system was provided, including where it was administered, lot# or adminitering personnel
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Pemphigus
Clinical narrative: Narrative:  Pt reported to nursing with 24 hours from 2nd moderna vaccine, exacerbation of existing Phempigus Vulgaris which was treated by non-clinic Dermatologist with Magic Mouthwash. Symptoms lasted approx.. 3 weeks.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Narrative: Error-3rd dose given
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Nausea
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for advanced age, hypercholesterolemia, secondary malignant neoplasm of bone, prostate cancer, HTN, glaucoma, diabetes, vitamin d deficiency. Patient was under the care of palliative medicine, with poor prognosis. 3/12 per note, patient got nausea. Patient deceased 4/27/2021. No cause of death documented
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative: Timing Error only 2nd dose given too soon
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Narrative: Patient experience nausea, vomiting, and headache 2 days after receiving the first COVID-19 vaccination.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vomiting
Clinical narrative: Narrative:  Patient called into call center day after receiving first dose of vaccine - experiencing body aches, fever (101 F) and vomiting. Patient reported no symptoms consistent with allergic reaction, drinking fluids and eating well despite emesis. Patient contacted for follow up phone call on 3/29 and symptoms had resolved.
Age: 34.0
Sex: F
Vaccine: TDAP
Symptoms: Contusion, Rash erythematous, Urticaria
Clinical narrative: Narrative:  32 yo female received a Tdap vaccine in March 2021. A few days later, she secure-messaged her primary care team stating that for the past 5 days, she had red spots/bruising throughout her body she believed to be hives. She stated that she takes daily Zyrtec and started taking OTC Benadryl to help with the symptoms. She also stated that she gets hives from the influenza vaccine. She had a video Appointment with her PCP who suggested she sees an allergist prior to any other vaccinations such as the Covid vaccine.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Immunisation reaction
Clinical narrative: Narrative:  Patient experienced diarrhea one day after receiving the first dose of the COVID-19 vaccine. Patient visited the emergency department to seek treatment for the adverse reaction and received loperamide 2 mg PO four times daily for diarrhea. Symptoms improved after a few days of treatment.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling of body temperature change, Nausea
Clinical narrative: Narrative: Patient experienced nausea, fatigue, and alternating hot/cold flashes after receiving the second COVID-19 dose.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Narrative: Patient reported soreness in the arm in which they received the COVID vaccine (this was consistent with both doses of vaccine)
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash, Rash macular, Rash pruritic
Clinical narrative: Narrative:  Approximately one week after receiving 2nd COVID 19 vaccine,  patient reports he had arm swelling and rash to arm and neck. On 3/20/2021, ED physician described rash as flat pink macular rash over the left upper extremity and a fine pruritic rash on the left side of the neck. Patient prescribed diphenhydramine, triamcinolone cream, and medrol dose pack. Patient returned to  ED again on 3/25/2021 still complaining of symptoms despite medications  prescribed on 3/20/2021. ED physician added montelukast, hydroxyzine, and initiated a dexamethasone taper.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Catheterisation cardiac abnormal, Coronary artery disease, Death, Dyspnoea
Clinical narrative: Narrative:  Pt was a 67 YO male with PMH of DM, CAD, OSA on Bipap, Hemorrhagic stroke in 2018 who presented with shortness of breath and hemoptysis over last couple of days and was found to have BP in 200/100s. He was admitted to ICU at hospital where he underwent cardiac catheterization that showed extensive three vessel disease, severe pulm htn, elevated right and left filling pressures. On the morning of 4/6 he went into cardiac arrest and following 45 minutes of life support guidelines, he was pronounced dead.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoptysis, Intensive care, Pulmonary hypertension
Clinical narrative: Narrative:  Pt was a 67 YO male with PMH of DM, CAD, OSA on Bipap, Hemorrhagic stroke in 2018 who presented with shortness of breath and hemoptysis over last couple of days and was found to have BP in 200/100s. He was admitted to ICU at hospital where he underwent cardiac catheterization that showed extensive three vessel disease, severe pulm htn, elevated right and left filling pressures. On the morning of 4/6 he went into cardiac arrest and following 45 minutes of life support guidelines, he was pronounced dead.